Epitranscriptomic (m6A) pathway inhibitors in MPN
Current understanding
To be populated as evidence accumulates.
Evidence log
Open questions
Related
Contributing findings
"Beyond the Genetic Blueprint: Disrupting the Epitranscriptomic Code in Myeloproliferative Neoplasms".
16-oct-2026
novelty 4
per-area 4
introduces